Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UC Irvine
Dates
study started
completion around
Principal Investigator
by Maheswari Senthil, MD (uci)

Description

Summary

This is a pilot, single-arm, open label study to evaluate the ability of CYTALUX™ (pafolacianine) to help identify cancerous lesions in subjects with gastrointestinal cancers and peritoneal carcinomatosis during cytoreductive surgery.

Official Title

The Impact of Pafolacianine Injection for Intraoperative Imaging on Outcomes of Gastrointestinal Cancer Peritoneal Carcinomatosis - a Pilot Study

Keywords

Gastrointestinal Cancer, Peritoneal Carcinomatosis, Gastrointestinal Neoplasms, Carcinoma, Peritoneal Neoplasms, Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging, Pafolacianine (CYTALUX)

Eligibility

Location

  • Chao Family Comprehensive Cancer Center, University of California, Irvine accepting new patients
    Orange California 92868 United States

Lead Scientist at University of California Health

  • Maheswari Senthil, MD (uci)
    Clinical Professor, Surgery, School of Medicine. Authored (or co-authored) 94 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Irvine
ID
NCT06511037
Phase
Phase 1 research study
Study Type
Interventional
Participants
Expecting 10 study participants
Last Updated